Abstract: A processing device that processes a workpiece of a plate shape having a thickness direction along an upper-bottom direction includes a controller configured to control an operation of the processing device, a storing section storing the workpiece, a transfer section including a transfer hand on which the workpiece is placed and that moves the workpiece from and into the storing section, a processing section processing the workpiece, a holding section holding an upper surface of the workpiece, and a moving section horizontally moving the holding section between the transfer hand and the processing section. The holding section receives and places the workpiece from and on the transfer hand above the transfer hand. The processing section processes the workpiece from below and the workpiece is held by the holding section.

Abstract: A visual inspection apparatus and a visual inspection method enabling the quality of a state of solder to be properly judged. Specifically, in the visual inspection apparatus and visual inspection method, a slope (concave slope region) present on a surface of solder is searched and the quality of a state of the solder is judged based on that result. The quality of the state of the solder can be properly judged based on not a height of the solder, but the slope of the surface of the solder.

Abstract: A visual inspection apparatus and a visual inspection method enabling the quality of a state of solder to be properly judged. Specifically, in the visual inspection apparatus and visual inspection method, a slope (concave slope region) present on a surface of solder is searched and the quality of a state of the solder is judged based on that result. The quality of the state of the solder can be properly judged based on not a height of the solder, but the slope of the surface of the solder.

Abstract: A first X-ray image is obtained by imaging a target in a first direction and at a first elevation angle, and a second X-ray image is obtained by imaging the target in a second direction and at a second elevation angle. Based on these two X-ray images, cross-section data of the target is obtained. The first and second X-ray images are converted into first and second thickness data, and first cross-section data based on a first surface side of the target and second cross-section data based on a second surface side of the target are obtained based on the first thickness data. Similar third cross-section data and four cross-section data are obtained based on the second thickness data. The cross-section data of the target is obtained by partially extracting and synthesizing cross-section data of a highly reliable region from these pieces of cross-section data.

Abstract: A first X-ray image is obtained by imaging a target in a first direction and at a first elevation angle, and a second X-ray image is obtained by imaging the target in a second direction and at a second elevation angle. Based on these two X-ray images, cross-section data of the target is obtained. The first and second X-ray images are converted into first and second thickness data, and first cross-section data based on a first surface side of the target and second cross-section data based on a second surface side of the target are obtained based on the first thickness data. Similar third cross-section data and four cross-section data are obtained based on the second thickness data. The cross-section data of the target is obtained by partially extracting and synthesizing cross-section data of a highly reliable region from these pieces of cross-section data.

Abstract: A new cultivar of Primula plant named ‘HAK-P-01’ that is characterized by a short overall height, a compact habit and flowers that have a red-purple upper side and a red-purple under side with a white base.

Abstract: A new cultivar of Primula plant named ‘HAK-P-02’ that is characterized by a short overall height, a compact habit and flowers that have an upper side that is purple with a yellow-green base and an under side that is purple with a white base.

Abstract: A dieting agent is disclosed which comprises an aqueous solution or a solid substance of a concentration .alpha.-amylase inhibiting substance which is produced by a process which comprises heat treating a supernatant fraction of an aqueous extract of wheat or wheat flour to modify unnecessary protein contaminants in the supernatant fraction, removing a modified protein from said fraction, subjecting a resulting aqueous solution containing an .alpha.-amylase inhibiting substance to a concentration treatment using an ultrafiltration membrane to form an aqueous solution of a concentrated .alpha.-amylase inhibiting substance or drying the aqueous solution. The dieting agent exhibits a body weight gain-inhibiting effect.

Abstract: 4(3H)-Quinazolinone derivative of formula (I) are provided. ##STR1## wherein R.sub.1 is a hydrogen atom, a C.sub.1 -C.sub.6 alkyl group, an aryl group, a substituted aryl group, or an aralkyl group; R.sub.2 is a C.sub.1 -C.sub.6 alkylamino group, a phenyl group, a substituted phenyl group, or a 5- or 6-membered heterocyclic group containing one or more N, O or S as a hetero atom or atoms, said heterocyclic group optionally being substituted or fused with a benzene ring; n is 1 or 2; or R.sub.2 represents a geranyl group or a dipyridylmethyl group together with the group --(CH.sub.2).sub.n --; and X is a hydrogen atom, a C.sub.1 -C.sub.6 alkyl group or a halogen atom, and pharmaceutically acceptable acid addition salts thereof. They are useful as antiucler agents.

Abstract: Quinoxaline derivatives of formula (I) are provided. ##STR1## wherein A is a hydrogen atom or 2-quinoxalyl group, B is 2-pyridyl or 4-quinolyl group and n is 0 or 1, or a pharmaceutically acceptable acid addition salt thereof. They are useful as antiulcer agents.

Abstract: 2-Pyridylmethylthio derivatives of formula (I) are provided. ##STR1## wherein A represents 4-methyl-2-quinazolinyl, 4-(2-pyridylmethylthio)-1-phthalazinyl or 4-oxo-3-phenyl-3,4-dihydropyrido[2,3-d]pyrimidine-2-yl, or a pharmaceutically acceptable acid addition salt thereof. They are useful as antiulcer agents.

Abstract: Compounds are described of formula (I) ##STR1## wherein R.sup.1 is a hydrogen atom, an alkyl group, an alkoxy group, a dialkylamino group or a halogen atom; n is 1 to 4; R.sup.2 is a hydrogen atom, an alkyl group, an unsubstituted or substituted aminoalkyl group, an acyl group, an unsubstituted or substituted aralkyl group, a carboxyalkyl group, an alkoxycarbonyalkyl group or ##STR2## wherein X is an unsubstituted or substituted-phenyl, -benzyl, -benzoyl or -furoyl group; A is -NR.sup.3 - where R.sup.3 is hydrogen or alkyl, an alkylene or an alkylidene; and B is a heterocyclic group selected from triazolyl, pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, benzimidazolyl, benzothiazolyl, quinolyl and isoquinolyl, said heterocyclic group being optionally substituted by one or more alkyl, alkoxy, nitro or phenyl group, and the physiologically acceptable acid addition salts thereof. The compound of formula (I) are or cardiotonic activity and thus may be useful for the treatment of circulatory diseases.

Abstract: Compounds are described of the formula ##STR1## wherein R.sub.1 is a nitro or trifluoromethyl group; R.sub.2 is a C.sub.1 -C.sub.6 alkyl group; R.sub.3 is a pyridyl or pyridyl N-oxide group which may be substituted with halogen, hydroxyl, haloalkyl, C.sub.1 -C.sub.6 alkoxy or C.sub.1 -C.sub.6 alkyl and further may be fused with a benzene or naphthalene ring, said ring being optionally substituted with C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkoxy, halogen or haloalkyl, and a pharmaceutically acceptable acid addition salt thereof. The compounds of the formula (I) are of vasodilating and blood pressure lowering activities and thus may be useful for the treatment of cardiac diseases, cerebrovascular diseases and hypertension.

Abstract: 4(3H)-Quinazolinone derivatives of formula (I) are provided. ##STR1## wherein R.sub.1 is a hydrogen atom, a C.sub.1 -C.sub.6 alkyl group, an aryl group, a substituted aryl group, or an aralkyl group; R.sub.2 is a C.sub.1 -C.sub.6 alkylamino group, a phenyl group, a substituted phenyl group, or a 5- or 6-membered heterocyclic group containing one or more N, O or S as a hetero atom or atoms, said heterocyclic group optionally being substituted or fused with a benzene ring; n is 1 or 2; or R.sub.2 represents a geranyl group or a dipyridylmethyl group together with the group --(CH.sub.2).sub.n --; and X is a hydrogen atom, a C.sub.1 -C.sub.6 alkyl group or a halogen atom, and pharmaceutically acceptable acid addition salts thereof.They are useful as antiulcer agents.

Abstract: 2-Alkylsulfinyl-4(3H)-quinazolinone derivatives of formula (I) are provided. ##STR1## wherein R.sub.1 is a C.sub.1 -C.sub.6 alkyl group, an aryl group, a substituted aryl group or an aralkyl group, R.sub.2 is a phenyl group, a substituted phenyl group or a 5- or 6-membered heterocyclic group containing one or more N, O or S as a hetero atom or atoms, said heterocyclic group optionally being substituted or fused with a benzene ring, n is 1 or 2 and X is hydrogen, a C.sub.1 -C.sub.6 alkyl group or a halogen atom, and pharmaceutically acceptable acid addition salts thereof. They are useful as antiulcer agents.

Abstract: 4-Thioquinazoline derivatives of formula (I) are provided. ##STR1## wherein R.sup.1 is a C.sub.1 -C.sub.6 alkylamino group, a phenyl group, a substituted phenyl group or a 5- or 6-membered heterocyclic group containing one or two N, O or S as a hetero atom or atoms, said heterocyclic group optionally being substituted or fused with a benzene ring; n is 1 or 2; or R.sup.2 is a hydrogen atom or a C.sub.1 -C.sub.6 alkyl group, and pharmaceutically acceptable acid addition salts thereof. They are useful as antiulcer agents.

Abstract: 2,6-Dimethyl-4-(2- or 3-substituted phenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid diesters, having vasodilating and blood pressure lowering effects, in the ester moiety at the 3-position of which a heterocyclic group is linked to an alkylene group through an ester bond (carbonyloxy group). The diesters are used for treatment of cardiac diseases, cerebrovascular diseases and hypertension.

Abstract: Four different optical isomers of a new compound, 1-[2'-(o-methoxyphenoxy)-1'-methylethylamino]-3-(4"-isocarbostyriloxy)-2-p ropanol are now provided as new substances. These four optical isomers are now named as (2R, 1'S)-1-[2'-(o-methoxyphenoxy)-1'-methylethylamino]-3-(4"-isocarbostyriloxy )-2-propanol, (2S, 1'S)-1-[2'-(o-methoxyphenoxy)-1'-methylethylamino]-3-(4"-isocarbostyriloxy )-2-propanol, (2S, 1'R)-1-[2'-(o-methoxyphenoxy)-1'-methylethylamino]-3-(4"-isocarbostyriloxy )-2-propanol, and (2R, 1'R)-1-[2'-(o-methoxyphenoxy)-1'-methylethylamino]-3-(4"-isocarbostyriloxy )-2-propanol, respectively. These four optical isomers have different activities for their .beta.-adrenergic-blocking effect and .alpha.-adrenergic-blocking effect and are useful as valuable agents for therapeutic treatment of various cardiovascular diseases, as compared to an optically inactive racemic mixture of said isomer compounds.

Abstract: A new cultivar of Primula plant named ‘HAK-P-01’ that is characterized by a short overall height, a compact habit and flowers that have a red-purple upper side and a red-purple under side with a white base.

Abstract: A new cultivar of Primula plant named ‘HAK-P-02’ that is characterized by a short overall height, a compact habit and flowers that have an upper side that is purple with a yellow-green base and an under side that is purple with a white base.